CA2117430A1 - Brofaromine utilisee pour le traitement du stress post-traumatique - Google Patents

Brofaromine utilisee pour le traitement du stress post-traumatique

Info

Publication number
CA2117430A1
CA2117430A1 CA002117430A CA2117430A CA2117430A1 CA 2117430 A1 CA2117430 A1 CA 2117430A1 CA 002117430 A CA002117430 A CA 002117430A CA 2117430 A CA2117430 A CA 2117430A CA 2117430 A1 CA2117430 A1 CA 2117430A1
Authority
CA
Canada
Prior art keywords
brofaromine
traumatic stress
treating
pharmaceutically acceptable
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002117430A
Other languages
English (en)
Inventor
Richard Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2117430A1 publication Critical patent/CA2117430A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA002117430A 1992-02-21 1993-01-27 Brofaromine utilisee pour le traitement du stress post-traumatique Abandoned CA2117430A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83963992A 1992-02-21 1992-02-21
US07/839,639 1992-02-21

Publications (1)

Publication Number Publication Date
CA2117430A1 true CA2117430A1 (fr) 1993-09-02

Family

ID=25280288

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002117430A Abandoned CA2117430A1 (fr) 1992-02-21 1993-01-27 Brofaromine utilisee pour le traitement du stress post-traumatique

Country Status (7)

Country Link
EP (1) EP0626849A1 (fr)
JP (1) JPH07503972A (fr)
KR (1) KR950700063A (fr)
AU (1) AU676672B2 (fr)
CA (1) CA2117430A1 (fr)
NZ (1) NZ249041A (fr)
WO (1) WO1993016695A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579899B1 (en) 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
CA2337507A1 (fr) * 1998-07-16 2000-01-27 Massachusetts Institute Of Technology Composition pour le traitement du stress
JP2003511698A (ja) * 1999-10-12 2003-03-25 コンネクス・ゲゼルシャフト・ツーア・オプティミエルング・フォン・フォルシュング・ウント・エントヴィックルング・エムベーハー 便中の酸耐性微生物の改良された検出方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH592656A5 (fr) * 1973-03-02 1977-10-31 Ciba Geigy Ag
AU3595093A (en) * 1992-02-21 1993-09-13 Ciba-Geigy Ag Brofaromine as an agent for treating social phobia

Also Published As

Publication number Publication date
EP0626849A1 (fr) 1994-12-07
KR950700063A (ko) 1995-01-16
AU3484493A (en) 1993-09-13
AU676672B2 (en) 1997-03-20
NZ249041A (en) 1997-07-27
WO1993016695A1 (fr) 1993-09-02
JPH07503972A (ja) 1995-04-27

Similar Documents

Publication Publication Date Title
DE60132723T2 (de) Zusammensetzungen bestehend aus Dipeptidylpeptidase-IV Inhibitoren und Antidiabetica
Burns et al. Phencyclidine—: States of Acute Intoxication and Fatalities
DE69113386T2 (de) Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
EP0276536B1 (fr) Emploi de buspirone pour la modification de la mémoire à court terme
DE60009697T2 (de) Verwendung von 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie
JPS60146824A (ja) 鎮痛用組成物
DE3590035T1 (de) Diphenhydramin enthaltende, analgetische und anti-inflammatorische Mittel und Verfahren zu ihrer Verwendung
MX2012001814A (es) Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso.
US4278679A (en) Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
JPH0320222A (ja) 脳内虚血症治療剤
CA2117430A1 (fr) Brofaromine utilisee pour le traitement du stress post-traumatique
JPH04503805A (ja) コカイン常用癖の治療薬
US5905086A (en) Remedy for anxiety neurosis
Shelton et al. Simulated abuse of tybamate in man: Failure to demonstrate withdrawal reactions
TWI289060B (en) Pharmaceutical composition for improving the recovery of post-stroke patients
JP3150642B2 (ja) 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法
JP2003530350A (ja) 外傷性脳損傷及びその他のニューロン障害治療用医薬
Thornton Sleep aids and sedatives
Davis et al. Shingles (herpes zoster) and post-herpetic neuralgia
WO1993016696A1 (fr) Utilisation de la brofaromine comme agent de traitement de la nevrose phobique
DE69816790T2 (de) Verbesserung der opioid-toleranz durch hemmung der induzierbaren stickstoffoxid-synthase zur behandlung von schmerzen
JPH01197485A (ja) 恐慌状態の予防または断絶のための薬剤
CA3209781A1 (fr) Utilisation de luvadaxistat pour le traitement d'une deficience cognitive
Hall et al. Psychiatric and physiological reactions produced by over-the-counter medications
HUSSAR New drugs

Legal Events

Date Code Title Description
FZDE Dead